This Sources Sought opportunity from Department Of Veterans Affairs was posted on July 9, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

Q301--NGS Malignancy Testing

Closed

36C25026Q0709Federal

Submission Closed07/14/2026, 12:00:00 PM EDT

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 621511

New

Federal

Rodent Histopathology and Toxicologic Pathology ServicesThis subcontract for Rodent Histopathology and Toxicologic Pathology Services supports prime contractors on Environmental Protection Agency projects within the Tribal and Science Division Water. The scope of work involves the processing and evaluation of maternal and neonatal rodent specimen organs to analyze the biological effects of air pollutants, phthalates, PFAS, and endocrine-disrupting compounds. The selected provider must utilize specialized histology equipment for slide preparation and pathology analysis while maintaining strict adherence to GLP regulations and EPA Quality Assurance Program requirements. Key deliverables include the provision of comprehensive histopathology reports and evaluated pathology data.

Tribal & Science Division Water

POSTED

DEADLINE

Semen Analysis (SA) and Post-Vasectomy Semen Analysis (PVSA) Laboratory ServicesThis subcontract opportunity is for the provision of specialized clinical laboratory services, specifically semen analysis and post-vasectomy semen analysis, to support prime contractors on Department of Veterans Affairs VISN 22 projects. The selected provider will be responsible for receiving and processing specimens, performing the required analyses, and delivering validated test reports. To be eligible, the contractor must possess a current Clinical Laboratory Improvement Amendments certificate and maintain facilities specifically equipped for andesmic and semen analysis. Strict adherence to HIPAA privacy regulations is mandatory. This is a total small business set-aside under NAICS code 621511, managed by the Department of Veterans Affairs Network Contract Office 22.

262-NETWORK Contract Office 22 (36C262)

POSTED

DEADLINE

Q301--VISN 22 Semen & Vasectomy Test Kits

Solicitation # 36C26227Q0056-0001

The Department of Veterans Affairs, Network Contracting Office 22, is soliciting a firm-fixed-price contract for specialized referral laboratory services to perform semen analysis and post-vasectomy semen analysis. This comprehensive, end-to-end service requirement includes the provision of at-home collection kits with a minimum six-month shelf life, patient logistics, specimen shipping, laboratory testing, and result reporting via a secure web portal. The contractor must maintain current Clinical Laboratory Improvement Amendments (CLIA) certification and ensure strict compliance with HIPAA and Department of Transportation regulations regarding the handling and transport of biological specimens. Award will be based on the best value to the government, evaluating technical ability to meet the statement of work, price, and transportation and delivery factors. Key performance metrics include a 95% success rate for specimen integrity and timely delivery, and a 90% adherence to test turnaround schedules. The contract is a small business set-aside and is structured for a five-year period consisting of a base period and four option periods. Invoicing is handled monthly through the Contracting Officer, with payments made in accordance with the Prompt Payment Act.

262-NETWORK Contract Office 22 (36C262)

POSTED

DEADLINE

Drug Demand Reduction Program (DDRP)

Solicitation # W50S8227QA002

The 175th Wing is establishing a local and state level Drug Demand Reduction Program (DDRP) service contract for the Maryland Air National Guard. This total small business set-aside procurement, under solicitation W50S8227QA002, requires the provision of trained personnel to serve as Drug Testing Program Administrative Managers (DTPAM) and Observers. These personnel will be responsible for specimen collection, packaging, and on-site observation in strict accordance with DAFMAN 44-197, DAFMAN 44-198, and relevant Department of Defense instructions. Services will be performed at the 175 Wing in Middle River, Maryland, and a Geographically Separated Unit in Fort Meade, Maryland, primarily during regularly scheduled drill weekends between 0700 and 1700. The contract structure consists of a one-year base period with four additional one-year option periods. Award will be granted to the responsible offeror deemed most advantageous to the government based on price and other factors. Key deliverables include a Quality Control Plan submitted within 15 days of award, DTPAM appointment letters and training certificates, and signed observer statements. Performance will be monitored via a Quality Assurance Surveillance Plan and a Performance Requirements Summary. Administrative requirements include the use of Wide Area WorkFlow for electronic invoicing and compliance with various FAR and DFARS clauses, including cybersecurity safeguards and the Buy American program.

W7ND Uspfo Activity Mdang 175

POSTED

DEADLINE

NWI Offsite Pathology Services

Solicitation # 36C26326R0063

The Department of Veterans Affairs, Nebraska-Western Iowa Health Care System, is soliciting a Fixed Price, Indefinite Delivery, Indefinite Quantity (IDIQ) contract for offsite medical laboratory, pathology, and testing analysis services. The selected contractor will be responsible for pre-analytic processing, analysis, and reporting of clinical and anatomical pathology specimens, including the provision of all necessary personnel and specialized collection and transportation supplies. While the VA handles most specimen collection and preparation, the contractor is responsible for grossing global surgical pathology cases and must return all slides and blocks to the VA for permanent storage. The contract features a five-year ordering period beginning April 1, 2027, with a total small business set-aside. Award will be based on the Lowest Priced Technically Acceptable (LPTA) quote, with technical acceptability contingent upon CAP, Joint Commission, and CLIA accreditations, as well as a review of past performance from the previous five years. The contractor must adhere to strict quality standards outlined in the Quality Assurance Surveillance Plan, including a 100 percent accuracy rate for specimen labeling and specific turnaround times for cytology and autopsy reports. Key requirements include compliance with HIPAA, the Privacy Act, and hazardous materials regulations for transporting biological substances. The contractor must also maintain specific insurance coverages, including general liability and employer's liability, and ensure all personnel undergo background investigations per VA security standards.

Network Contract Office 23 (36C263)

POSTED

DEADLINE

Non-DOT Drug Testing Laboratory ServicesThe Massachusetts Bay Transportation Authority is seeking a subcontract for Non-DOT Drug Testing Laboratory Services to support prime contractors on various drug testing projects. The selected provider will be responsible for the analysis and reporting of urine specimens for non-DOT regulated employees and applicants. This includes identifying negative, non-negative, and confirmed positive results, as well as managing outcomes related to dilute, adulterated, substituted, invalid, or cancelled specimens. To qualify for this engagement, the laboratory must maintain CLIA accreditation and be capable of delivering comprehensive laboratory test reports. Interested parties should note that the response deadline is December 8, 2026, and the services fall under NAICS code 621511.

Massachusetts Bay Transportation Authority

POSTED

DEADLINE

DOT Drug Testing Laboratory ServicesThis subcontract for DOT Drug Testing Laboratory Services involves the analysis and reporting of urine specimens for prime contractors working on Massachusetts Bay Transportation Authority drug testing projects. The selected provider will be responsible for determining a wide range of results, including negative, non-negative, confirmed positive, dilute negative, adulterated, substituted, invalid, and cancelled statuses, while performing necessary confirmation testing for all non-negative results. To qualify, the provider must operate a DOT-certified laboratory that strictly adheres to all DOT regulatory standards to ensure the delivery of certified laboratory test results. This opportunity is categorized under NAICS code 621511, with a response deadline set for December 8, 2026.

Massachusetts Bay Transportation Authority

POSTED

DEADLINE

RFP 124-26 Lab Drug Testing

Solicitation # BD-27-1206-40000-40000-135345

The Massachusetts Bay Transportation Authority (MBTA) is soliciting proposals under RFP 124-26 (Solicitation BD-27-1206-40000-40000-135345) for a laboratory to provide DOT and Non-DOT drug testing for employees and applicants. The selected provider must be capable of analyzing a wide range of specimen outcomes and ensuring secure electronic transmission of results to the MBTA Drug Program system. All DOT testing must comply with 49 CFR Part 40 and HHS Mandatory Guidelines, while Non-DOT testing will generally follow the same processes. The scope of work includes managing the end-to-end testing process from courier collection to result transmission to the Medical Review Officer (MRO). The contract will be awarded on a best-value basis, evaluating a combination of technical capability, supplier diversity, and price. Bidders must submit a comprehensive proposal via COMMBUYS, including a technical response covering turnaround times, testing capabilities, system integration, and courier services. The MBTA requires strict adherence to labor laws, anti-discrimination statutes, and human trafficking prohibitions. While the contract does not require performance guarantees, liquidated damages, or specific security requirements, it does mandate compliance with MBTA minimum insurance requirements and specific safety training for personnel working near rail transit lines. Payment is processed through the MBTA invoicing system with a standard review period of fifteen days.

Massachusetts Bay Transportation Authority

POSTED

DEADLINE

Clinical Laboratory Analysis and TestingThis subcontract for Clinical Laboratory Analysis and Testing involves performing laboratory analysis of biological samples to support prime contractors on NIMHD health disparities research projects. The selected provider will be responsible for processing samples and conducting assays using specialized diagnostic equipment and laboratory facilities. All work must be performed in strict accordance with Good Clinical Laboratory Practices (GCLP) to ensure compliance. The primary deliverables for this engagement include the provision of laboratory test results and validated data reports. This opportunity is associated with the National Institutes of Health Olao under the Department of Health and Human Services.

National Institutes Of Health Olao

POSTED

DEADLINE

PHPA 4166: Maryland Volunteer and Professional Firefighters Innovative Cancer Screening Technologies Program

Solicitation # BPM058949

The Maryland Department of Health, Center for Cancer Prevention and Control, is offering grants through the Maryland Volunteer and Professional Firefighters Innovative Cancer Screening Technologies Program (PHPA 4166/BPM058949). This initiative provides funding to local fire departments, volunteer fire companies, and local governments to procure and administer innovative cancer screening tests that are not typically covered by insurance or offered during routine physical examinations. Eligible applicants must be Maryland-based and are required to assemble a healthcare team to select appropriate tests, oversee the screening process, and provide participants with necessary counseling and navigation to diagnostic services. The program has a total funding allocation of 900,000 dollars, which will be distributed among multiple awards on a pro rata basis based on evaluation scores. Technical and financial factors are weighted equally during the selection process, with a preference for tests supported by strong clinical evidence, those utilizing novel technologies, and tests capable of screening for multiple cancer types simultaneously. The performance period for the grants is scheduled from March 1, 2027, to June 30, 2027. Funding is provided on a reimbursement basis, requiring grantees to maintain accurate records and submit invoices and financial reports to the Maryland Department of Health. Applications must be submitted via the eMaryland Marketplace Advantage portal by November 20, 2026.

POSTED

DEADLINE

Biospecimen Logistics and Repository ServicesThe Biospecimen Logistics and Repository Services subcontract, issued by the National Institutes of Health under the Department of Health and Human Services, focuses on the collection, transfer, and storage of biospecimens for research network projects. The selected provider will be responsible for managing physical sample movement and coordinating with national repositories through the use of cold chain logistics and LIMS software. Performance of these services will take place in Bethesda. To ensure safety and quality, the contractor must adhere to CLIA/CAP standards and maintain IATA certification for the handling of hazardous biological materials. The primary objective is the secure transfer and detailed cataloging of biospecimens. Interested parties must respond by November 23, 2026, under NAICS code 621511.

National Institutes Of Health Nichd

POSTED

DEADLINE

STAT and Routine Clinical Laboratory AnalysisThis subcontract involves providing comprehensive clinical laboratory analysis, monitoring, and reporting services for prime contractors supporting the Department of Veterans Affairs at the Buffalo VAMC. The scope of work includes the delivery of 24/7 STAT and routine testing, specifically including semen analysis, with results transmitted via phone, fax, and hard copy. To qualify for this engagement, the provider must maintain a New York State Department of Health Clinical Laboratory Permit, a CLIA License, and CAP Accreditation. The opportunity is categorized under NAICS code 621511 and is managed through the Department of Veterans Affairs Network Contract Office 02.

242-NETWORK Contract Office 02 (36C242)

POSTED

8 days ago

DEADLINE

in 6 days

AI Contract Overview

The Richard L. Roudebush VAMC is seeking information from qualified businesses capable of providing a one-year, firm fixed price contract for Hematologic Malignancy Next Generation Sequencing (NGS) and Immunohistochemistry (IHC) testing and analysis of patient specimens. NGS testing must analyze at least 600 targeted genes from blood samples to deliver detailed genetic profiles and customized treatment plans, primarily to support cases where repeat testing is required outside the scope of the VA National Precision Oncology Program due to diagnostic changes. The requirement falls under NAICS code 621511, with performance to be conducted in Indianapolis, Indiana, and the government is not currently obligated to award a contract or allocate funds. This notice is strictly for market research and planning purposes, and submissions will not constitute a solicitation, nor will respondents be entitled to reimbursement for any costs incurred in preparing their responses. Vendors interested in responding must provide their point of contact information including UEI, SAM.gov registration, NAICS code, socio-economic status, and GSA/FSS contract number if applicable. A capability statement demonstrating expertise in NGS and IHC services for hematologic malignancies is required, along with up to three relevant past performance examples. All responses must be submitted via email by July 14, 2026, at 12:00 PM EST to Jessica D. Bryant or Tiera T. Sims at the designated VA email addresses only; no phone calls or postal submissions will be accepted. Proprietary information in submissions must be clearly marked, as the government will handle such data with confidentiality but will not compensate any party for the information provided.

General Info

VA seeks NGS and IHC testing vendors for hematologic malignancies, one-year firm fixed price, Indianapolis, submission by July 14, 2026.

Agency

Department Of Veterans Affairs → 250-NETWORK Contract Office 10 (36C250)

NAICS

621511 - Medical Laboratories

Place of Performance

Richard L. Roudebush VAMC 1481 W. 10th St., Indianapolis, IN, 46202, USA

Set-Aside

NONE

Documents

sow

High

sources-sought

Low

AI Contract Breakdown

Uniform Contract Format

View Full Breakdown

Timeline

PhaseClosed

PostedJul 9

Sources Sought

Response DeadlineJul 14

Deadline has passed

Submission Closed

07/14/2026, 12:00:00 PM EDT

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyDepartment Of Veterans Affairs → 250-NETWORK Contract Office 10 (36C250)

Contacts1 person available

OfficeDAYTON, OH, 45428, USA

Organization / AgencyDepartment Of Veterans Affairs → 250-NETWORK Contract Office 10 (36C250)

Office AddressDAYTON, OH, 45428, USA

Contacts

Jessica D. BryantContract Specialist

Full Description

SOURCES SOUGHT NOTICE This Sources Sought Notice is to determine the presence of any businesses capable of satisfying a requirement at the Richard L. Roudebush VAMC for Hematologic Malignancy Next Generation Sequence (NGS) complex specialized testing and Immunohistochemistry (IHC) testing and analysis of patient specimens. NOTE TO RESPONDERS: This Sources Sought Notice is for planning purposes only and shall not be considered as an invitation for bid, request for quotation, request for proposal, or as an obligation on the part of the Government to acquire any products or services. Your response to this Sources Sought Notice will be treated as information only. No entitlement to payment of direct or indirect costs or charges by the Government will arise as a result of contractor submission of responses to this announcement or the Government use of such information. This request does not constitute a solicitation for proposals or the authority to enter negotiations to award a contract. No funds have been authorized, appropriated, or received for this effort. BACKGROUND The Hematology department at Richard L. Roudebush VA Medical Center s Pathology & Laboratory Medicine Service (PALMS) requires a one-year, firm fixed price contract for Hematologic Malignancy Next Generation Sequence (NGS) complex specialized testing and Immunohistochemistry (IHC) testing and analysis of patient specimens. NGS testing is an advanced test methodology at the gene level for detecting various forms of diseases through patient blood specimens. Testing shall provide detailed gene test results of at least 600 targeted genes and produce detailed treatment plans. This contract is needed for Hematology providers to obtain repeat NGS testing that may not be covered under the VA National Precision Oncology Program (NPOP) national contract, for patients with changes in their diagnosis. North American Industry Classification System (NAICS) code: 621511 VENDOR CAPABILITY Interested and qualified vendors are encouraged to respond with: Your company s point of contact s name, street address, e-mail address, telephone number, UEI & sam.gov registration, NAICS code, and Socio-economic status (Small Business, Woman Owned Small Business, Service-Disabled Veteran Owned Small Business, etc.), and GSA/FSS Contract Number (if applicable). A capability statement that adequately describes the contractor s ability to meet the requirement. Contractor shall provide any applicable past performance on contracts of this nature. Please provide no more than three (3) examples.
Interested parties are responsible for adequately marking proprietary information contained in their response. The Government does not intend to pay for the information submitted in response to this Sources Sought Notice. All information received in response to this notice that is marked as proprietary will be handled accordingly.
GOVERNMENT POINT OF CONTACT No phone calls will be accepted. Responses will only be accepted via email, no later than Tuesday July 14, 2026, at 12pm EST. Primary Point of Contact: Jessica D. Bryant Contract Specialist E-mail:
Secondary Point of Contact: Tiera T. Sims Contract Specialist E-mail: